Technique for cataract surgery in eyes with neovascularization of the anterior segment

Session Details

Session Title: Cataract Surgery Special Cases

Session Date/Time: Monday 12/09/2016 | 08:00-10:30

Paper Time: 09:56

Venue: Auditorium C6

First Author: : A.Pérez-Arteaga MEXICO

Co Author(s): :                        

Abstract Details

Purpose:

To compare the outcomes in cataract surgery in eyes with neovasclarization of the anterior segment, between a traditional phacoemulsification technique and a technique with specifical variations.

Setting:

Centro Oftalmológico Tlalnepantla, México.

Methods:

100 cases of cataract surgery with neovascularization of the anterior segment were operated by one surgeon, with some variations of technique (preoperative use of antiangiogenic, sustained high intraoperative intraocular pressure, use of intracameral epinephrine, avoid the use of miotic agents and postoperative pupil dilation). The outcomes (intra and postoperative complications), were measured and compared with another 83 eyes previously operated by the same surgeon, with out the use of the described variations in the technique. Eyes with previous retinal photocoagulation and vítreous hemorrhage were excluded.

Results:

The incidente of intra and postoperative complications (intra and postoperative bleeding of the anterior segment, postoperative vítreous hemorrhage, postoperative increase in the neovascularization of the posterior segment and possibility of rapid onset postoperative retinal photocoagulation), were improved with stadistical significance, in the group operated with the variations of the technique in contrast with the eyes operated with traditional phacoemultification.

Conclusions:

The incidente of intra and postoperative complications when operating a cataract surgery in an eye with neovascularization of the anterior segment, is drastically reduced with the use of preoperative injection of antiangiogenic medication, the use of intraoperative intracameral epinephrine, the use of high intraoperative intraocular pressure, the use of postoperative midriatic agents, the avoid of intraoperative low intraocular pressure and the avoid of intraoperative and postoperative miotic agents.

Financial Disclosure:

NONE